| Literature DB >> 30660866 |
Benjamin Schmid1, Kennie R Prehn2, Natakarn Nimsanor3, Blanca Irene Aldana Garcia4, Ulla Poulsen2, Ida Jørring2, Mikkel A Rasmussen2, Christian Clausen2, Ulrike A Mau-Holzmann5, Sarayu Ramakrishna6, Ravi Muddashetty7, Rachel Steeg8, Kevin Bruce8, Peter Mackintosh8, Andreas Ebneth9, Bjørn Holst2, Alfredo Cabrera-Socorro9.
Abstract
Alzheimer's disease (AD) is the most frequent neurodegenerative disease amongst the elderly. The SNPs rs429358 and rs7412 in the APOE gene are the most common risk factor for sporadic AD, and there are three different alleles commonly referred to as APOE-ε2, APOE-ε3 and APOE-ε4. Induced pluripotent stem cells (iPSCs) hold great promise to model AD as such cells can be differentiated in vitro to the required cell type. Here we report the use of CRISPR/Cas9 technology employed on iPSCs from a healthy individual with an APOE-ε3/ε4 genotype to obtain isogenic APOE-ε2/ε2, APOE-ε3/ε3, APOE-ε4/ε4 lines as well as an APOE-knock-out line.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30660866 DOI: 10.1016/j.scr.2018.11.010
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020